DIA Biosimilars 2013

Articles Published in 2009

JLL Partners Completes Acquisition of PharmaNet

Tuesday, March 31, 2009 09:36 AM

Contract research organization (CRO) PharmaNet is officially a private company after private equity firm JLL Partners completed its acquisition of the CRO yesterday.

More... »

Cenduit: Now with Patient Reminders

ICON Teams Up with MedAvante for CNS Trials

Monday, March 30, 2009 08:00 AM

Dublin, Ireland-based contract research organization (CRO) ICON is partnering with MedAvante, a provider of psychological rating services, to improve the efficiency and effectiveness of central nervous system (CNS) clinical trials.

More... »

CRF Health – eCOA Forum

ClearTrial Appoints New COO

Friday, March 27, 2009 11:17 AM

ClearTrial, a provider of clinical trial software, appointed Michael Bruns as the company’s new chief operating officer. Bruns will oversee ClearTrial’s global operations and help further develop and implement the company’s growth strategy. Prior to joining ClearTrial, Bruns was director of the Technology Investment Banking Group at Robert W. Baird, a global investment banking firm.

More... »

WuXi Revenues Up 87% in 2008

Thursday, March 26, 2009 07:28 AM

Chinese contract research organization (CRO) WuXi Pharmatech reported an 87% increase in 2008 revenues compared with 2007, with net revenues for continuing operations of $253.5 million. Fourth-quarter 2008 net revenues from continuing operations increased 74% to $64.4 million compared with fourth quarter 2007. The CRO’s non-GAAP net income for 2008 was $58.3 million, up 31% from $44.6 million in 2007.

More... »

Oracle to Acquire Relsys

Wednesday, March 25, 2009 08:00 AM

Business software company Oracle has agreed to acquire Relsys, a provider of drug safety and risk management applications, for an undisclosed amount. The deal is expected to close by summer.

More... »

Covance Acquires Swiss Pharma Contract

Tuesday, March 24, 2009 07:43 AM

Covance has expanded its clinical pharmacology presence in Europe with the recent acquisition of Swiss Pharma Contract, a contract research organization (CRO) in Basel, Switzerland, for an undisclosed sum.

More... »

IRB Uncovers Congressional 'Sting' Operation

Monday, March 23, 2009 09:00 AM

Source: Coast IRB

More... »

Guest Commentary: Suicidality Monitoring in Pharmaceutical Clinical Trials

Friday, March 20, 2009 08:00 AM

Dr. Michael McKelvey, CEO of ERT , a leading provider of centralized ECG and eClinical technology, ePRO, and other services to the biopharmaceutical, medical device, and related industries, discusses the benefits of electronic patient reported outcomes (ePRO) tools for assessing and monitoring suicidality in clinical drug trials.

More... »

Start-up Spaulding Clinical Thrives Despite Economy

Thursday, March 19, 2009 08:00 AM

Late last year may not have seemed like the best time to launch a new business but that’s exactly what Randy Spaulding did when he opened the doors to Spaulding Clinical in West Bend, Wisc., in August.

More... »

i3 Streamlines Clinical Trial Management With New Technology

Wednesday, March 18, 2009 09:18 AM

Contract research organization (CRO) i3 launched a new web-based clinical trial and data management program that will replace the need for multiple systems and applications to manage study activities.

More... »

`
CenterWatch Drugs in Clinical Trials Database Library. Drug intelligence right at your fingertips.
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs